Published in Eksp Klin Gastroenterol on January 01, 2007
[Realities and prospects for the use of cell technologies for the treatment of chronic diffuse liver diseases]. Eksp Klin Gastroenterol (2011) 0.80
[The treatment of primary biliary liver cirrhosis with rifampicin]. Ter Arkh (1993) 0.79
[Antiproliferative activity of diclofenac at tumor cell cultures]. Eksp Klin Gastroenterol (2012) 0.79
[Role of stress in the etiopathogenesis of duodenal ulcer in young patients]. Eksp Klin Gastroenterol (2002) 0.77
[Level of blood uric acid in patients with postinfarction heart failure]. Ter Arkh (2000) 0.77
[The damaging role of endogenous nitric oxide in the development of the experimental DSS-induced colitis in rats]. Eksp Klin Gastroenterol (2010) 0.76
[Bone mineral density in patients with gluten-sensitivity celiac disease]. Ter Arkh (2010) 0.76
Investigation of cholesterol, bilirubin, and protein distribution in human gallstones by color cathodoluminescence scanning electron microscopy and transmission electron microscopy. Scanning (1998) 0.76
[Pharmacokinetic and pharmacodynamic characteristics of antihypertensive drugs in the treatment of hypertensive patients with chronic diseases of the liver]. Ter Arkh (2011) 0.76
[Efficiency of famotidin in prophylaxis of NSAIDs-induced gastropathy: result of multicenter research ZASLON-1 (protection of gastric mucosa from non-steroidal anti-inflammatory drugs]. Eksp Klin Gastroenterol (2009) 0.75
[Polymorphism of GPIIIA platelet glycoprotein gene PIA1/A2 compared to plasma hemostasis in myocardial infarction patients]. Ter Arkh (1999) 0.75
[Nitric oxide and indicators of oxidative stress in patients with exacerbation of chronic pancreatitis]. Eksp Klin Gastroenterol (2011) 0.75
[Role of cholestasis in development of copper metabolism disorder in patients with chronic liver disease]. Eksp Klin Gastroenterol (2009) 0.75
[Bone mineral density infringement in patients with digestive system diseases]. Eksp Klin Gastroenterol (2011) 0.75
[Modern approach to the prevention and treatment of NSAID-gastropathy]. Eksp Klin Gastroenterol (2011) 0.75
[Monooxigenase activity in liver diseases (study based on data of antipyrine metabolism)]. Ter Arkh (1987) 0.75
[Prevalence and clinical-morphological characteristics of anemia in patients with chronic liver diseases]. Eksp Klin Gastroenterol (2010) 0.75
[The role of E2 and F2alpha prostaglandins in development of erosive-ulcerative lesions of the gastroduodenal region]. Eksp Klin Gastroenterol (2009) 0.75
[Characteristics of the intestinal dysbiosis and endotoxemia after hemicolectomy]. Eksp Klin Gastroenterol (2011) 0.75
[Efficacy of lisinopril and nebivolol therapy of portal hypertension and kidney dysfunction in patients with liver cirrhosis]. Eksp Klin Gastroenterol (2008) 0.75
[Bone mineral density in patients with celiac disease and medical treatment of the disorder]. Eksp Klin Gastroenterol (2011) 0.75
[Peculiarities of diabetes mellitus course in chronic pancreatitis]. Eksp Klin Gastroenterol (2011) 0.75
[Exocrine function of the pancreas at chronic pancreatitis: diagnosis an drug correction]. Eksp Klin Gastroenterol (2009) 0.75
[Diagnosis of spontaneous bacterial peritonitis in liver cirrhosis]. Eksp Klin Gastroenterol (2008) 0.75
[Protein that binds fatty acids (I-FABP)--a new perspective evidence for injury of the small intestine]. Eksp Klin Gastroenterol (2011) 0.75
[Antipyrine metabolism and rat liver ultrastructure in single and combined action of trichlorodiphenyl and dioctyl phthalate]. Biull Eksp Biol Med (1992) 0.75
[Endoscopic retrograde cholangiopancreatography: standards of the procedure]. Eksp Klin Gastroenterol (2009) 0.75
[Pharmacokinetics of enalapril and metoprolol in hypertensive patients with hepatic pathology]. Ter Arkh (2007) 0.75
[Gilbert's syndrome: a clinicogenetic trial]. Ter Arkh (2006) 0.75
[Experimental NSAID-associated gastric mucosa injuries]. Eksp Klin Gastroenterol (2008) 0.75
[Bone mineral density in patients with liver cirrhosis]. Eksp Klin Gastroenterol (2009) 0.75
[Clinical and diagnostic significance of gepsidin level in the regulation of iron metabolism in patients with inflammatory bowel disease]. Eksp Klin Gastroenterol (2011) 0.75
[Experimental study of NSAID effect on prostaglandine contents]. Eksp Klin Gastroenterol (2007) 0.75
[Celecoxib and Tramadol as an alternative osteoarthrosis therapy in patients with NSAID gastropathy]. Eksp Klin Gastroenterol (2004) 0.75
[Functional renal reserve of patients with liver cirrhoses]. Eksp Klin Gastroenterol (2007) 0.75
[New possibilities for overcoming the secondary inefficiency of anti-cytokine therapy in patients with inflammatory bowel diseases]. Ter Arkh (2013) 0.75
[Oncogenesis humoral mechanisms regulation and NSAIDs ability in prevention of tumors]. Eksp Klin Gastroenterol (2011) 0.75
[Combination therapy of arterial hypertension combined with liver pathology. The place of angiotensin converting enzyme inhibitors]. Kardiologiia (2009) 0.75
[Cytomegalovirus infection in patients with ulcerative colitis]. Eksp Klin Gastroenterol (2010) 0.75
[The frequency of anemia among patients of gastroenterological hospital]. Eksp Klin Gastroenterol (2011) 0.75
[Modeling damage of the mucous membrane of the gastrointestinal tract in rats]. Eksp Klin Gastroenterol (2011) 0.75
[Nonalcoholic fatty liver disease and insulin resistance: clinical, biochemical, and morphological parallels]. Eksp Klin Gastroenterol (2008) 0.75
[Disorder of mineral density of the bone tissue in patients with chronic pancreatitis]. Eksp Klin Gastroenterol (2008) 0.75
[Causes of biliary sludge]. Ter Arkh (2003) 0.75
[Fosinorm in the treatment of essential hypertension with a metabolic syndrome]. Ter Arkh (1997) 0.75
[Disorders of bone mineral density in patients with cholelithiasis and postcholecystectomic syndrome]. Eksp Klin Gastroenterol (2010) 0.75
[Changes in concentration of cholecystokinin-pancreozymin in patients with cholelithiasis before and after cholecystectomy]. Eksp Klin Gastroenterol (2010) 0.75
[Quality of life of patients with hyperendotoxemia after hemicolectomy]. Eksp Klin Gastroenterol (2011) 0.75
[Change of nitric oxide metabolites in patients with chronic pancreatitis]. Eksp Klin Gastroenterol (2008) 0.75
[Risk of development of clinical and pathogenetic features of anemia on the background of basic therapy of inflammatory bowel disease]. Eksp Klin Gastroenterol (2011) 0.75
[Diagnostic potential of a new functional test used in intestinal diseases--determination of hydrogen in exhaled air]. Ter Arkh (1991) 0.75
[Efficacy of chondroitin sulphate in the treatment of elderly patients with gonarthrosis and coxarthrosis]. Ter Arkh (2005) 0.75
[Lipid peroxidation markers in the exhaled breath and microsomal oxidation in patients with chronic diffuse liver diseases]. Ter Arkh (1995) 0.75
[Features of bone metabolism in patients with chronic diseases of digestive system]. Eksp Klin Gastroenterol (2011) 0.75
[Detoxifying function of the liver in patients with rubromycosis during treatment with antimycotics]. Vestn Dermatol Venerol (1989) 0.75
[The role of the population risk factors in the genesis of osteo metabolism in patients with chronic diseases of the digestive system]. Eksp Klin Gastroenterol (2011) 0.75
[VITAMIN D DEFICIENCY AS A FACTOR POLYMORBIDITY]. Eksp Klin Gastroenterol (2015) 0.75
[Diagnostic value of interleukin-6 level during the post-operative period]. Klin Lab Diagn (1999) 0.75
[Laboratory diagnostics of acute pancreatitis]. Eksp Klin Gastroenterol (2003) 0.75
[Variations and frequency of distribution of quantitative value of acetylcholine and cholinesterase activity in blood serum of healthy persons]. Eksp Klin Gastroenterol (2007) 0.75
[Fecal excretion of short-chain fatty acids as a marker of the severity of ulcerative colitis]. Ter Arkh (2010) 0.75
[Spontaneous bacterial peritonitis: scientific and practical achievements and prospects]. Eksp Klin Gastroenterol (2011) 0.75
[The clinical significance of hereditary and acquired alpha-1-antitrypsin deficiency in patients with liver cirrhosis and Wilson-Konovalov disease]. Eksp Klin Gastroenterol (2010) 0.75
[ACE inhibitors in the treatment of patients with arterial hypertension and pathology of the digestive system]. Eksp Klin Gastroenterol (2007) 0.75
[Role of exocrine pancreatic insufficiency in reducing of the bone mineral density in patients with chronic pancreatitis]. Eksp Klin Gastroenterol (2010) 0.75
[Effect of enzyme supportive therapy of the Ermital' on a quality of life of patients with chronic pancreatitis]. Eksp Klin Gastroenterol (2010) 0.75
[Deficiency of essential microelements in patients with diseases of the digestive system]. Eksp Klin Gastroenterol (2011) 0.75
[Plasma hemostasis and biochemical indices in trimetazidine treatment of patients with chronic heart failure]. Ter Arkh (1998) 0.75
[Nitric oxide as an inflammation marker at non-specific ulcerous colitis and Crohn's disease]. Eksp Klin Gastroenterol (2006) 0.75
[Violations of colon microbiocenosis and lipid metabolism after hemicolectomy]. Eksp Klin Gastroenterol (2010) 0.75
[Non-steroidal anti-inflammatory drugs and tramadol in the treatment of osteoarthrosis deformans in patients with arterial hypertension]. Klin Med (Mosk) (2004) 0.75
[The angiotensin-converting enzyme inhibitor perindopril in the treatment of congestive heart failure]. Ter Arkh (1997) 0.75
[Antipyrine test in evaluating the detoxifying function of the liver in chronic diseases]. Ter Arkh (1982) 0.75
[Protective hepatotropic effect of preparations from mussels and ginseng during exposure of animals to dioctylphthalate]. Biull Eksp Biol Med (1994) 0.75
[Interconnection in activity of lipid peroxidation reactions and functional status of the liver in patients with chronic hepatitis of viral etiology]. Eksp Klin Gastroenterol (2002) 0.75
[The specific features of pancreatic incretory dysfunction in chronic pancreatitis]. Ter Arkh (2012) 0.75
[Hydrogen test: its diagnostic possibilities in intestinal diseases]. Klin Med (Mosk) (1990) 0.75
[Vitamin D exchange and its active metabolite at celiac disease]. Eksp Klin Gastroenterol (2010) 0.75
[Pharmacokinetics of iron medication and efficacy of therapy with oral iron supplementation]. Eksp Klin Gastroenterol (2011) 0.75
[Pharmacokinetics of preparations of lipoic acid and their effect on ATP synthesis, processes of microsomal and cytosol oxidation in hepatocytes in liver damage in man]. Farmakol Toksikol (1989) 0.75
[Role of nitric oxide (NO) in the etiopathogenesis of certain alimentary diseases]. Eksp Klin Gastroenterol (2005) 0.75
[Syndrome of iron overload and its impact on the clinical course and risk of complications in patients with liver cirrhosis]. Eksp Klin Gastroenterol (2011) 0.75
[Atenolol and metoprolol differentiated therapy of patients with arterial hypertension complicated by pathology of the digestive tract organs]. Eksp Klin Gastroenterol (2008) 0.75
[Spontaneous bacterial peritonitis and systemic inflammatory reaction in hepatic cirrhosis patients]. Ter Arkh (2011) 0.75
[Disorder of bone mineral density in patients with the digestive system diseases]. Eksp Klin Gastroenterol (2011) 0.75
[Effect of ursodeoxycholic acid for reducing the deficit of vitamin D status and bone mineral density at gallstones]. Eksp Klin Gastroenterol (2010) 0.75
[Preparations of alpha-lipoic acid: the dynamics of their content in the blood and their effect on hemostasis in lesions of the human liver]. Farmakol Toksikol (1990) 0.75
[Effect of hepatitis C virus genotype on viral load and clinical-laboratory characteristics of liver disease]. Eksp Klin Gastroenterol (2010) 0.75
[New approaches to diagnostics of spontaneous bacterial peritonitis in liver cirrhosis]. Eksp Klin Gastroenterol (2008) 0.75
[Spontaneous bacterial peritonitis in liver cirrhosis: optimization issues of prevention and treatment]. Eksp Klin Gastroenterol (2012) 0.75
[Complex interpretation of aggregatograms for assessing the functional activity of platelets in patients with hypertension]. Klin Lab Diagn (1999) 0.75
[Replicative activity of hepatitis B as a factor determining the progression of liver fibrosis and cirrhosis]. Eksp Klin Gastroenterol (2011) 0.75
[Diagnostic value of serum markers of fibrosis in chronic liver diseases]. Ter Arkh (2013) 0.75
[Etiology and pathogenesis of duodenal mucosa lesion in chronic pancreatitis]. Ter Arkh (2009) 0.75
[Violation of bone mineral density tissue and its correction in patients with celiac disease]. Eksp Klin Gastroenterol (2011) 0.75
[Computer system for image analysis of fluorescently stained bacteria]. Mikrobiologiia (2007) 0.75